Articles Posted in Dangerous Drugs

Published on:

Reyes Law - Dallas Texas

Testosterone replacement products bring in billions for drug companies each year. Some experts say that number could reach $5 billion by 2017.

Critics say drug companies pushed misleading ads to men seeking the fountain of youth.

In 2014, the consumer watchdog group Public Citizen petitioned the FDA to include a black box warning on safety labels. The agency initially responded to the petition by saying the FDA has not concluded that FDA-approved testosterone treatment increases the risk of stroke, heart attack, or death. But in 2015, the FDA reconsidered and ordered drug makers to add stroke and heart attack warnings to labels and safety information.

Now, eight lawsuits that allege testosterone drugs caused heart attacks and blood clots will be heading to trial in 2017, according to court documents.

Continue reading →

Published on:

Blood Monitor Device Tainted Xarelto Clinical Trials

A new drug’s effectiveness and safety are tested and verified by studies and clinical trials conducted by independent third parties such as universities and scientific labs. From a drug company’s perspective, receiving the endorsement of a successful clinical trial is essential to successfully marketing a new drug. Drug companies and their salesman use the results of these studies and trials as sales tools to market the drug to doctors. A pharmaceutical company can make billions of dollars by developing a drug that is more effective than another, providing doctors with an incentive to buy one to replace the other. In 2015 alone, Johnson and Johnson made $1.9 billion dollars selling Xarelto, an anti-clotting drug used to treat patients who are in danger of having a stroke. The future of this drug is now in question, however, because one of the testing devices used in the clinical trial has been deemed to be defective.

Continue reading →

Published on:

Are Testosterone Gel's Modest Benefits Worth The Risk?

Testosterone is a hormone produced naturally in the testicles beginning at puberty and gradually decreases after age 30. By the time a male reaches age 65 his testosterone levels are significantly lower, leaving some men feeling tired, lethargic, and with a reduced libido. As a treatment for this condition, doctors have been prescribing testosterone therapy, low-t for short, usually in the form of rubbing a gel on the body. The objective of the therapy is to restore a percentage of the testosterone lost due to aging. Men by the millions have been lured by slick advertising and have started taking the therapy. It has been said that given the frenzy over this new anti-aging treatment, some doctors prescribe the treatments without measuring a man’s testosterone to see if it was low in the first place.

Continue reading →

Published on:

005

The benefits of taking the anti-depressant drug Paxil have always been marginal at best and the serious consequences of it’s side effects have been either misrepresented or downplayed. When an initial study of the now-popular antidepressant was conducted on 100 patients with depression-related psychological issues, patients were given 3 different pills and the results of their mood recorded. The first group was given Paxil. The second group was given the existing leading prescription antidepressant, and a third group given a placebo. Results of the study concluded that there was no discernible difference in a standard depression questionnaire given all of the patients. Paxil did rate better on another test of mood measures but this was only on a secondary level.

Continue reading →

Published on:

006

While Johnson and Johnson enjoys an excellent reputation as one of America’s leading medical companies, it might surprise some people to discover that over 90% of Johnson and Johnson’s net income is derived from sales of pharmaceutical drugs and medical products and not “shampoo and baby powder” that has branded the company “squeaky clean”. And while you’ll rarely hear this coverage in the local media, Johnson and Johnson is coming under fire and losing lawsuits for the way they have marketed their billion-dollar antipsychotic drug Risperdal.

Continue reading →

Published on:

Five new and potentially dangerous weight loss drugs have been approved by The U.S Food and Drug Administration after rejecting every single new weight loss drug for the previous 13 years.

In the five weight loss drugs that have been approved, the potentially harmful side effects include suicidal thinking, increased heart rate, increased cancer risks and others. In addition, there is no proof that these FDA-approved diet drugs do anything to improve the health problems that obesity caused in the first place such as a higher risk for heart disease and other cardiovascular issues like high blood pressure, heart attacks and strokes. Below is a list of the five new weight loss drugs recently approved by the USFDA and a brief description of what they are supposed to do and their potentially dangerous side effects.

Continue reading →

Published on:

nodrugs-300x225Prescription drugs aren’t always safe. In fact, the U.S. Food and Drug Administration has recalled a number of prescription drugs and many drugs are under review because research has linked the drugs to dangerous side effects. Here’s a list of 10 potentially dangerous prescription drugs on the U.S. market today.

Low Testosterone Drugs

Research has linked low testosterone drugs to an increased risk of heart attack and stroke. Researchers published their results in November 2013 in the Journal of the American Medical Association as well as in PLOS One in 2014.

Published on:

hidden-dangers-of-generic-prescription-drugs-300x300When brand name prescription drug manufacturers learn that their product has caused harm to a customer, they are required to notify doctors and potential consumers by sending letters or by adding an additional warning to their product label. However, the same rule does not apply to the manufacturers of generic drugs.

Currently, brand name drug manufacturers face liabilities under the “failure to warn” legal theory that says if they do not act quickly enough to keep others safe, they are held responsible. Generic drug manufacturers don’t have to worry about that. Instead, generic drug manufacturers are not allowed to change the labels on their products until the brand name equivalent has done the same. Once a brand name manufacturer has developed a new label resulting from potential harm to consumers, the FDA must approve it before it can be put into place.

Does the 2013 Generic Drug Supreme Court Ruling Place Consumers In Danger?

Published on:

low-testosterone-problems-300x199It is tough to turn on the TV these days and not see an advertisement for testosterone replacement therapy at some point. Getting more popular by the minute, testosterone replacement therapy promises to help men who suffer from low testosterone, or low T, to gain back the chemical that made them the men they were in their glory days. However, despite the growing popularity, there is little evidence to suggest that this treatment works and is worth the risks associated.

Testosterone treatment promises to give men more energy, the libido of a 20-year-old, and ability to have the muscle definition they once showed off. However, these results come with hefty risks. The two most common and deadly side effects of testosterone treatment are prostate cancer and heart attack.

Low T Therapy Risks May Outweigh Benefits

Published on:

low-testosterone-may-cause-harm-300x198Low-testosterone drugs are one of the most heavily prescribed drugs on the market, as low-T affects millions of middle-aged men. While low-T drugs have been available to the public via prescription for years, a September 2014 panel for the Food and Drug Administration recommended that drug manufacturers look into whether the drugs may increase users’ risk of heart attack and stroke.

Dangerous Side Effects of Low-T Drugs

The biggest concern facing those who take low-T drugs is the increased risk of stroke, heart attack, and death. A 2013 study published in the Journal of the American Medical Association monitored 8,709 men with low testosterone who underwent a coronary angiography in the Veterans Administration health system between 2005 and 2011, 1,223 of whom started low-T therapy after the coronary angiography.

Contact Information